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Background: Up to 80% of United States (U.S.) citizens will contract the human papillomavirus 
(HPV) at some point in their lives. HPV has the ability to cause multiple types of cancer, 
including cervical, vulvar, vaginal, penile, anal, and oropharyngeal. The most recent HPV 
vaccine is effective against nine strains of the virus, which account for most cases of cancer and 
genital warts caused by HPV. Parents are a key component in reaching Healthy People 2030’s 
goal to have 80% of all adolescents in the U.S. completely vaccinated against HPV. Objective: 
The purpose of this systematic review was to determine if parental education regarding the 
implications associated with contracting an HPV infection and the development of cancer and 
knowledge of the impact of the HPV vaccine on HPV infection rates (and thus cancer 
prevention) could increase adolescent vaccination initiation and completion rates in the U.S. 
Results: Research does not strongly support education as a sole intervention to achieve Healthy 
People 2030’s goal. Findings: Multiple interventions are likely necessary to impact HPV 
infection and vaccination rates in adolescents, including parental education, policy change, 
public health campaigns, and public health interventions such as school-based vaccination 
clinics.  
Keywords: Vaccine hesitancy, vaccine refusal, vaccine compliance, vaccine uptake, HPV 
vaccine, HPV vaccination, human papilloma virus vaccine, papillomavirus, education, teaching, 
instruction, parents, caregivers, mother, father, parent, United States of America, America, US, 




Parental Education on Implications of HPV Infection in Their Adolescent Children:  
Can This Increase HPV Vaccination Initiation and Completion Rates?  
 Human papillomavirus (HPV) is the most common sexually transmitted infection in the 
United States (U.S.), with up to 80% of citizens contracting this infection during their lifetime 
(Niccolai & Hansen, 2015). Up to 50% of infected individuals contracted HPV during their first 
sexual encounter (Niccolai & Hansen, 2015). More than 32% of female adolescents age 14 to 19 
years old have contracted HPV (Dorell et al., 2014). This infection is well known to cause 
multiple types of cancer, including cancer of the cervix, vulva, vagina, anus, penis, and 
oropharynx (Brewer et al., 2020; Lee et al., 2016; Lu et al., 2015; Schnaith et al., 2018; Thomas 
et al., 2012). Seventy percent of the world’s cervical cancer cases are caused by HPV strains 16 
and 18, both of which are vaccine preventable (Lee et al., 2016). Brewer et al. (2020) assert there 
are 42,000 new cases of cancer diagnosed annually in the U.S. per year that can be attributed to 
HPV. Oropharyngeal squamous cell carcinoma is now the leading HPV associated cancer in the 
U.S. (Schnaith et al., 2018). HPV can also cause non-cancerous diseases, such as genital warts 
(Moss et al., 2016a). HPV can also be asymptomatic, allowing individuals to unknowingly 
spread this infection (Lu et al., 2015; Niccolai & Hansen, 2015).  
The HPV vaccine became available in the United States in 2006, with initial 
recommendations solely for girls. Recommendations for boys were added in 2010 (Thomas et 
al., 2012). The nine-valent HPV vaccine (Gardasil 9) is the most recent HPV vaccine, approved 
for use in 2014 (Lee et al., 2016). This vaccine protects the individual from strains of HPV that 
cause 95% of genital warts and 90 to 95% of anogenital cancers (Brewer et al., 2020). Current 
guidelines recommend vaccinating against HPV at 11 to 12 years of age, as the vaccine is most 




2016a; Victory et al., 2019). If greater than 80% of U.S. adolescents become fully vaccinated 
against HPV, it is estimated that 56 to 86% of abnormal Papanicolaou tests, cervical cancer, and 
anal cancer could be prevented and genital warts would become nearly eradicated (Brewer et al., 
2020).  
Despite the prevalence of HPV-related cancers in the United States, HPV vaccination 
rates have failed to meet Healthy People 2020’s goal of 80% of adolescents completing the 
vaccine series (Healthy People, 2020; Kornides et al., 2018). Only 49.5% of female and 37.5% 
of male adolescents age 13 to 17-years-old have completed the HPV vaccine series (Schnaith et 
al., 2018; Victory et al., 2019). Looking at HPV vaccination rates from a global perspective, 
developed countries like Australia, England and Denmark report that more than 70% of their 
adolescent populations have completed the HPV vaccine series (Niccolai & Hansen, 2015). If the 
U.S. could meet the goal of fully vaccinating 80% of adolescents against HPV, an estimated 
53,000 cases of lifetime cervical cancer diagnoses could be prevented (Victory et al., 2019).  
Background 
Phenomenon of Interest  
 The focus of this paper is to identify how parental education regarding the long-term 
health outcomes surrounding contracting an HPV infection impact adolescent vaccine uptake. 
Current efforts have failed to meet Healthy People 2020’s goal for 80% of adolescent males and 
females to complete the HPV vaccination series (Healthy People, 2020). Healthy People 2030 is 
repeating this goal since the United States fell short of achieving the 2020 HPV vaccination 
goals (Healthy People 2030, n.d.). Patients under the age of 18 in the U.S. must have parental 
consent to get vaccinated. Thus, gaining parental support of the HPV vaccine is a key step in 





 In light of the U.S. public health goal of increasing HPV vaccination rates in the U.S., the 
following clinical question was developed. Does focused parental education regarding HPV and 
its role in cancer development impact HPV vaccine uptake in adolescents (age 9 to 18 years of 
age)?  
Significance for Advanced Practice 
 Nurses have historically been among the most trusted professions in the United States 
(Moss et al., 2016a). Nurse practitioners are in a position to impact parental decision making 
regarding the HPV vaccine and their adolescent children. Patient education is a fundamental 
aspect of nursing. Many studies in this literature review identify lack of education as a barrier to 
the HPV vaccine uptake. Other studies also found that parental education increases acceptance of 
the vaccine (Niccolai & Hansen, 2015; Thomas et al., 2012; Victory et al., 2019). Nurse 
practitioners have an opportunity to initiate conversation about HPV and the vaccine, which 
gives parents a chance to ask questions and nurse practitioners a chance to clarify misperceptions 
about the vaccine. Understanding the role parental knowledge plays in initiating and completing 
the HPV vaccine series is critical for advanced practice providers.  
 Nurse practitioners as a profession have expanded access to healthcare in the U.S., 
especially for individuals in rural and underserved communities. Rural communities historically 
have had low rates of HPV vaccination in both male and female adolescents (Thomas et al., 
2012). Underserved communities in the U.S. have higher rates of HPV associated cancers than 
the general population. For example, Southeast Asian American females have the highest rate of 
cervical cancer of all ethnic groups (Lee et al., 2016). Geographic disparities in HPV vaccine 




HPV vaccination (Moss et al., 2016a). As an example, the Rio Grande Valley in Texas is 
geographically rural, with its residents more likely to be of Hispanic descent and to experience 
economic disadvantages, low health literacy, less education, and less access to medical care 
(Victory et al., 2019). Nurse practitioners have the ability to increase access and encourage HPV 
vaccination in all adolescents, promoting health within their communities and the nation as a 
whole (Fenton et al., 2017).  
Methods 
Search Strategies and Data Abstraction 
 A thorough systematic literature review was conducted between the dates of 11/13/2020 
and 1/21/2021 using CINAHL, PubMed, and Cochrane Database. Information covered in these 
databases included nursing and allied health, healthcare, evidence-based medicine, nursing, 
dentistry, veterinary medicine, health care systems, and preclinical sciences. Table 1 (see 
Appendix) reviews restrictions added to the literature search. Keyword combinations were used 
to further narrow research articles pertaining to the area of interest. Key words used for this 
process included vaccine hesitancy, vaccine refusal, vaccine compliance, vaccine uptake, HPV 
vaccine, HPV vaccination, human papilloma virus vaccine, papillomavirus, education, teaching, 
instruction, parents, caregivers, mother, father, parent, United States of America, America, US, 
USA, teen, adolescent, and preteen. Table 2 (see Appendix) further addresses keyword 
combinations used for this review. Number of articles matching keywords and keyword 
combinations were also included in Table 2 (see Appendix). Searches that retrieved 100 or fewer 
articles triggered a review of article titles and abstracts. Complete studies were read if titles and 
abstracts pertained to the research question. Ninety studies were reviewed, and 33 articles met all 




Inclusion and Exclusion Criteria 
Articles utilized in this review included parents of U.S. adolescents ages 9 through 18 
years of age; parental education on HPV, HPV’s role in cancer development, and the HPV 
vaccine; full text articles written in the English language; peer reviewed; recommendations on 
how providers should approach vaccine hesitancy; and recommendations for parental education. 
Studies that included a discussion surrounding state vaccination policies and HPV vaccination 
rates were also included for review. Studies were excluded if education was only directed 
towards adolescents; parents of children over age 18 years of age; or included participants from 
countries outside of the U.S. Table 3 addresses further inclusion and exclusion criteria (see 
Appendix). 
Literature Review 
 The literature review process revealed multiple types of research studies to include in this 
paper. This section will discuss findings from the studies included for analysis after completion 
of the systematic review.  
Study Characteristics 
Types of research  
Research designs included in this study are clinical reports, cohort studies, cross sectional 
studies, qualitative studies, systematic reviews (including randomized and non-randomized 
designs), quasi-experimental studies, expert opinions, randomized trials, and non-randomized 
control trials. Levels of evidence from these studies ranged from level I through level VII. Table 
4 (see Appendix) addresses further insights into research articles included in this systematic 
review.  




Populations studied included mothers, fathers, caregivers and guardians of adolescents 
ranging from nine to 18 years of age; individuals belonging to the Caucasian, Hispanic, 
multicultural Hawaiian, African American, Cambodian American, and Native American (Hopi) 
races; along with healthcare workers and medical students.  
Interventions  
Multiple methods of communication were utilized to provide education on HPV, the 
HPV vaccine, and health outcomes associated with HPV infection. Written educational 
information was disseminated via handouts (ex. Bright Futures), flyers, posters, postcards, 
pamphlets, fact sheets, booklets, and vaccine information available in the clinic. Public 
communications, including radio and billboard advertisements, spread information to 
communities. Digital education resources included educational images posted on public social 
media accounts, website advertising, informational web pages, and DVD’s. Verbal educational 
interventions included physician-led presentations to parents, adolescents, school staff, school 
nurses, family and pediatric primary providers, medical school students, and mother/daughter 
dyads. In one study, health professionals provided educational information to parents of 
adolescents over the telephone. Some studies addressed education on HPV for multidisciplinary 
clinic employees. 
Some studies included multiple interventions, aside from parental education, aimed at 
increasing HPV vaccination rates in adolescents. Such interventions included motivational 
interviewing, patient prompts (ex. reminder magnets, text messages, or phone calls for next 
dose), role playing simulations with a vaccine-hesitant parent, provider prompts (ex. EMR 




parental interviews, questionnaires, surveys, provider vaccine recommendation, and education 
for providers on best practices for recommending the vaccine. 
Research Synthesis 
Education 
Healthcare provider role 
Patient education is a core component of a health care provider’s role. Research supports 
the notion that parents prefer to receive education about HPV and their child’s health directly 
from their provider, rather than alternate sources (Dela Cruz et al., 2016; Litton et al., 2011). 
Education should highlight the vaccine’s ability to prevent certain types of cancers, as well as 
dispelling common myths such as encouraging premarital and unprotected sex (Brewer et al., 
2020; Suryadevara et al., 2019). 
Public health campaigns  
Brewer et al. (2020) utilized a “Boot Camp Translation” to create messages for the local 
public in Mesa County and the Denver metro area, aiming to increase adolescent uptake of the 
HPV vaccine. HPV messaging was dispersed among the communities with social media 
messages, posters, and educational materials provided in pediatric primary care clinics (Brewer 
et al., 2020). Educational messages and materials were tailored to the specific community the 
researchers targeted, such as individuals with low health literacy in the Denver metro area. 
Brewer et al.’s (2020) study was published very recently, so researchers are continuing to 
monitor the campaign’s outcome on HPV vaccination rates. However, researchers identified that  
different communities preferred campaign messages that emphasized different aspects of the 
vaccine (ex. cancer prevention vs. misconceptions) (Brewer et al., 2020). This may be useful 




Educational motivators for adolescents and parents 
Studies found in the literature review indicated that parents who were educated about the 
HPV vaccine by their healthcare provider were more likely to vaccinate their adolescent 
daughters than if they did not receive this information (Litton et al., 2011). Highlighting the 
vaccine’s ability to prevent certain types of cancers has also shown modest improvement in 
adolescent HPV vaccination rates (Suryadevara et al., 2019). Suryadevara et al. (2019) studied 
the impact of educating healthcare providers and staff, parents, and adolescents on cancer 
prevention associated with the HPV vaccine. The study included multiple clinic sites, which 
yielded a 12-20% increase in series completion rate in pre-teens (11 to 12 years old), and an 
increase of 7-23% in teens (13 to 18 years old) (Suryadevara et al., 2019).  
 Despite the many educational intervention studies that exist, only one study was found 
that met the Healthy People 2020 goal (80% HPV vaccination completion rate post-intervention) 
using a parental educational intervention (Winer et al., 2016). The Winer et al. (2016) research 
team studied effects of a Hopi Native American mother-daughter educational intervention. 
Mother-daughter dyads were invited to a dinner featuring an educational presentation, with the 
intervention group’s focusing on HPV. Winer et al. (2016) found that Hopi mothers who learned 
about HPV were significantly more likely to initiate and complete the HPV vaccine series for 
their daughters than mothers whose educational presentation was on juvenile diabetes (the 
study’s control group). While only 20% of the intervention group’s females age 11 to 12 years 
had completed the vaccine series, 80% of 13 to 17-year-old females had completed the HPV 
vaccine series upon recheck.  
Fu et al. (2014) completed a systematic review of educational interventions aiming to 




adolescent HPV vaccination rates (Fu et al., 2014). Additionally, Fu et al. (2014) found that 
interventional literature does not accurately represent the United States’ population. Most studies 
only included literate individuals who had attained a level of higher education. Thus, it is 
difficult to attain an accurate understanding of how educational interventions work across more 
diverse populations based off existing literature.   
Factors Implicated in Parental Acceptance of the HPV Vaccine  
Provider recommendation plays a large role in parental HPV vaccine acceptance, 
regardless of the family’s sociodemographic group or race (Dela Cruz et al., 2016; Litton et al., 
2011; Sanderson et al., 2017; Schnaith et al., 2019; Victory et al., 2019). Other associated factors 
include parental trust in the provider, positive parental attitude and intention to vaccinate, use of 
preventive healthcare, patient’s mother (not both parents) decides on vaccination, insurance 
coverage of the HPV vaccine, increased parental knowledge of HPV and the vaccine, parental 
history of HPV risk, geographic region (rural vs. urban), age of the child, and parent gender 
(fathers are less likely to vaccinate daughters) (Fu et al., 2014; Victory et al., 2019).    
Factors Implicated in Parental Delay or Refusal of the HPV Vaccine  
Parents play a large role in their children’s immunizations, including the HPV vaccine. 
Up to 36% of parents refuse this vaccine for their children (Kornides et al., 2018). Research 
indicates there are a multitude of factors that cause parents to delay or refuse vaccinating their 
adolescents against HPV infection. Factors identified in this literature review included low 
parental knowledge about the vaccine, concerns about the vaccine’s safety and efficacy, belief 
that the vaccine encourages premarital sex, view the vaccine is unnecessary, believe their child is 




barriers to accessing the vaccine (ex. cost, inconvenience) (Brueggmann et al., 2015; Dorell et 
al., 2014; Kinder, 2016; Kirchhoff et al., 2019; Schnaith et al., 2018; Victory et al., 2019).  
Males and the HPV Vaccine   
 Even though HPV vaccination rates in adolescent males has significantly increased since 
the vaccine became available to boys, adolescent male HPV vaccination rates remain low (Lu et 
al., 2015). Lu et al. (2015) found the most common reason that parents did not vaccinate their 
male child was because they felt their provider did not recommend it. Other reasons for not 
vaccinating sons included parental lack of knowledge on the HPV vaccine, concern for safety, 
personal belief that it was not necessary, and that their son was not yet sexually active (Lu et al., 
2015). This study also found that white non-Hispanic males were significantly less likely to be 
vaccinated than Hispanic or non-Hispanic black male adolescents (Lu et al., 2015).  
 Mayer et al. (2013) studied parental and son beliefs about the HPV vaccine and sexual 
disinhibition. Both parents and sons felt that the adolescent male and his girlfriend would feel 
safer taking risks after vaccination (Mayer et al., 2013). Parental characteristics that were 
associated with increased likelihood to vaccinate their child included having a daughter who was 
vaccinated against HPV, parents that did not have a daughter, not having a strong belief that the 
vaccine would cause sexual disinhibition, and having liberal political views (Mayer et al., 2015). 
Parents with conservative political views were more likely to believe the HPV vaccine would 
cause sexual disinhibition, and potentially deter the parent from vaccinating their child (Mayer et 
al., 2015). Boys in this study who thought their peers approved of the vaccine were more likely 
to believe the vaccine would produce sexual disinhibition and did not view this negatively 
(Mayer et al., 2015).  




 How healthcare providers communicate education on the HPV vaccine is just as 
important as the education itself. Kornides et al. (2018) found that parents who reported they 
were highly satisfied or moderately satisfied with provider communication were more likely to 
vaccinate their adolescents against HPV than parents who reported low levels of satisfaction with 
provider communication. Parents were more satisfied with their provider’s communication if 
discussions were easy to understand, there was a clear recommendation to vaccinate against 
HPV, they were told the number of doses required for the adolescent, and allowed parents to ask 
questions (Kornides et al., 2018).  
 Additionally, providers should not immediately acquiesce if parents seem hesitant to 
vaccinate their adolescent. Many parents who are not sure if they want to vaccinate their child 
against HPV may initially respond with hesitancy, such as a question (Shay et al., 2018). 
However, Shay et al. (2018) found that when the provider persisted, such as providing an 
explanation on benefits of the vaccine or consequences of not vaccinating, parents who were 
initially hesitant ended up vaccinating their child at the same appointment. Shay et al. (2018) 
also found that when providers did not persist against initial parental hesitation, no adolescents 
received the HPV vaccine that day. To further support persistence rather than acquiescence, a 
persistent response took less than 4 minutes to discuss while acquiescent responses took greater 
than 5 minutes (Shay et al., 2018). With busy provider schedules, a persistent response to 
vaccine hesitant parents would save the provider valuable time for other health promoting 
opportunities. Clear recommendations, open lines of communication, and persistence should be 
used as communication tactics to increase the likelihood of vaccinating the adolescent patient 
against HPV.  




 Racial minority communities in the U.S. are disproportionately more likely to have 
poorer health outcomes related to HPV infection (Sanderson et al., 2017). Females that have a 
low income, are an ethnic minority, or an immigrant have higher cervical cancer rates compared 
to the general female population in the U.S. (Dela Cruz et al., 2016). African Americans are a 
cultural group that suffers from high rates of cancers caused by HPV (Fu et al., 2018). Due to 
barriers to healthcare, even if the African American community achieved high rates of HPV 
vaccination, it is estimated that they would continue to have the highest risk of morbidity from 
cancers caused by HPV (Fu et al., 2018). Hispanic American women are also more likely to be 
diagnosed with and die from cervical cancer than non-Hispanic white females (Brueggmann et 
al., 2015; Kaul et al., 2019). This disparity is thought to be related to the Hispanic female 
population experiencing high rates of HPV infection, lack of knowledge that HPV can cause 
cancer, lower health literacy levels, decreased healthcare access, and low rates of screenings and 
follow-ups (Brueggmann et al., 2015; Kaul et al., 2019).   
In order to improve HPV vaccination uptake in all racial and ethnic communities that are 
present in the U.S., parental and patient culture must be included. Fu et al. (2018) found that 
common concerns in the African American community, such as fear of medical experimentation 
or close social contacts with this concern, were powerful enough to cause parents to not 
vaccinate their adolescents against HPV. Educational interventions should consider social 
influences unique to the parent’s culture (Fu et al., 2018).  
 Providing educational materials that are culturally diverse and represent the racial and 
ethnic populations of a clinic’s patient base is also an important aspect of improving HPV 
vaccination rates among all races and ethnicities (Brueggmann et al., 2015; Dela Cruz et al., 




parent’s decision to vaccinate their adolescent. Relevance would mean incorporating testimonials 
and pictures of individuals from the same race or ethnicity, reflective of the local community’s 
population, as well as presenting information in languages besides English (Brueggmann et al., 
2015; Dela Cruz et al., 2016).  
Childhood Cancer Survivors 
 Individuals who have cancer during their childhood are at increased risk for developing 
another form of cancer later in life (Kirchhoff et al., 2019). Specifically, female childhood cancer 
survivors are 40% more likely to develop cancer from an HPV infection and males are 150% 
more likely than non-childhood cancer survivors (Kirchhoff et al., 2019). However, parents of 
childhood cancer survivors are less likely than the general population to vaccinate their 
adolescent against HPV (Kirchhoff et al., 2019). Parents who spoke with their child’s oncologist 
about vaccines and possible side effects were more likely to vaccinate their adolescent against 
HPV (Kirchhoff et al., 2019).  
Gaps in Literature 
This author noted a significant gap in literature regarding educational interventions 
aiming to increase adolescent male HPV vaccine series initiation and completion rates. 
Adolescent males have significantly lower rates for initiating and completing the HPV vaccine 
series. HPV can be spread from males to females and other males, so increasing vaccination rates 
in this population could theoretically slow the spread of HPV among the U.S.  population. In 
addition, many interventional studies focused mainly on non-Hispanic white females. Expanding 
studies to focus on parental educational interventions of a culturally and gender diverse 
population may shed light on how to reduce health disparities that currently exist in some racial 




initiation and completion rates must include parents of males and females, as well as individuals 
from a variety of races and ethnicities.  
Discussion 
Mixed Results and Clinical Practice 
 There were conflicting findings with regards to the efficacy of education as a sole 
intervention to increase the U.S. adolescent HPV vaccination rates in this literature review. Only 
one study among all the studies evaluated regarding parental education impacting vaccination 
completion rates met Health People’s 2020 goal (Winer et al., 2016). This is a promising 
intervention that deserves more research, both within the Native American population and the 
general U.S. population. Until further research using this type of intervention is replicated, it is 
difficult to say if the results from this study can be applied to other cultural groups within the 
U.S. Overall, educational interventions may have a positive impact on vaccination rates, but the 
impact is modest and likely not enough to attain Healthy People’s goal. Reaching the 80% 
vaccination goal will likely only be met with a multifaceted approach, with possible policy 
intervention. 
 However, a modest improvement is better than no improvement at all, and healthcare 
providers must not underestimate the important role they play in educating their patients and 
parents. Providers should always provide education on HPV infection, health implications, and 
the vaccine. Vaccinating youth against HPV has the ability to prevent multiple types of cancer, 
as well as genital warts, amongst this patient population. 
Improving the Adolescent Male Vaccination Rate 
 A large portion of available literature focuses on adolescent females, or both adolescent 




aimed specifically at increasing adolescent male HPV vaccination completion rates. Only 37.5% 
of male adolescents age 13 to 17-years-old have completed the vaccine series, far below Healthy 
People’s goal of 80% (Schnaith et al., 2018; Victory et al., 2019). HPV can cause cancer in both 
males and females, and infected males are able to transfer this infection to their sexual partners. 
Further efforts must be made to increase the adolescent male HPV vaccination rate, which has 
the potential to decrease cancer risk among both males and females.  
More research is needed to determine what, if any, parental educational interventions can 
increase male HPV vaccination rates. However, providers can incorporate findings from existing 
literature to identify possible teaching points. For example, reassuring parents that the vaccine 
does not cause sexual disinhibition may persuade hesitant parents to vaccinate their son. 
Providers should also reinforce the need to use barrier protection with sexual activity to protect 
against other forms of sexually transmitted infections.  
Unique Adolescent Populations 
 Certain adolescent populations may benefit from a specialty healthcare provider’s 
recommendation supporting the HPV vaccine. Kirchoff et al. (2019) found that parents of 
childhood cancer survivors were more likely to vaccinate their adolescent against HPV if their 
oncologist recommended it. Though primary care providers should recommend the vaccine, 
utilizing the patient’s multidisciplinary care could provide parents with more specific 
information on the HPV vaccine and childhood cancer survivors. This could be a worthwhile 
effort to increasing adolescent HPV vaccination rates.  
Reducing Health Disparities 
 Unfortunately, health disparities still exist in the U.S. As previously discussed, culture, 




increased morbidity and mortality from cancers caused by HPV. While preventing disease 
should be a goal for the entire U.S. population, efforts must be especially focused to prevent 
disease in populations that are most likely to experience adverse outcomes related to HPV 
infections. Strategies to reduce barriers, such as parental education, cost, time, and 
transportation, may be effective ways to increase adolescent HPV vaccination rates in 
populations most at risk for adverse outcomes. This may require broad public health efforts to 
vaccinate the greatest number of adolescents. An example could be increasing access to 
vaccinations in public schools. Unfortunately, time, finances, and available health care staff may 
exist as barriers to such efforts. Increasing public awareness on the importance of the HPV 
vaccine, and gaining the public’s support, may be necessary to advance such public health 
efforts. 
Implications for Future Practice 
Recommendations for Clinical Practice  
 How the HPV vaccine is offered to families can make a significant difference in parental 
acceptance rates. Nurse practitioners should “bundle” the HPV vaccine with other scheduled 
vaccines for 11 to 12-year-old patients, like meningococcal and Tdap vaccines (Kinder, 2016; 
Victory et al., 2019). Even though most schools do not require the vaccine for entry, providers 
should strongly and clearly recommend it and emphasize its ability to prevent certain types of 
cancers (Bernstein & Bocchini, 2017; Kinder, 2016; Kornides et al., 2018). The vaccine should 
be offered in the same way to both males and females (Victory et al., 2019). Each visit to the 
clinic should be viewed as an opportunity to vaccinate against HPV (Bernstein & Bocchini, 




 Having clinic staff hand out educational information may not be enough. Dela Cruz et al. 
(2016) found that parents preferred their child’s healthcare provider review the educational hand 
out with them. This would be a simple way to guide discussion on the HPV vaccine and provide 
pauses for parents to have a chance to ask about any questions or concerns they may have.  
 How providers communicate information about the HPV vaccine to parents can also 
impact a parent’s decision to vaccinate or not vaccinate (Kornides et al., 2018). Providers should 
reflect on how they currently present information on the HPV vaccine. Do they clearly give a 
strong recommendation to vaccinate male and female adolescents? Do they provide information 
that is easy to understand, no matter the parents’ education level? Do they provide enough time 
for parents to express concerns and ask questions? If not, the provider must aim to include these 
points into their HPV vaccine discussion.  
Recommendations for Research 
 After reviewing the literature, a few themes were identified as areas requiring further 
research. It is not clear if parental education alone is enough to provide a significant impact on 
adolescent HPV vaccination rates. Some of the literature reviewed found, or hypothesized, that 
the sole intervention of parental education increased adolescent HPV vaccination rates (Brewer 
et al., 2020; Brueggmann et al., 2016; Ferris et al., 2010; Hansen et al., 2016; Shay et al., 2018; 
Suryadevara et al., 2019; Victory et al., 2019; Winer et al., 2016). Other research studies suggest 
that multiple interventions are necessary for parents to initiate and complete their adolescent’s 
HPV vaccine series (Bernstein & Bocchini Jr., 2017; Dela Cruz et al., 2017; Dorell et al., 2014; 
Fu et al., 2014; Kaul et al., 2019; Lee et al., 2016; Moss et al., 2016a; Pasket et al., 2016; Roberts 
et al., 2018; Sanderson et al., 2019; Walling et al., 2016). Further research should be completed 




initiation and completion. Further research is also needed to determine which educational 
interventions can increase HPV vaccination rates among culturally diverse populations and 
support culturally competent care (Fu et al., 2014).  
 Winer et al. (2016) achieved an 80% HPV vaccine series completion rate in female 
participants age 13 to 17-years-old. This was the only study retrieved from the literature review 
that produced results that met Healthy People 2020’s goal. Further research is warranted to 
explore if a parent/child dinner with an educational presentation on HPV would produce similar 
results with fathers, sons, and individuals from communities outside the Hopi Native American 
reservation.  
 Future research should also focus on the role that provider education plays in adolescent 
HPV vaccination rates. Schnaith et al. (2018) utilized education on HPV, health outcomes 
associated with infection, and how to communicate with vaccine hesitant parents in a group of 
University of Minnesota medical students. Students then utilized this knowledge in simulations 
with vaccine hesitant parent scenarios. This study found that the education increased the 
students’ confidence in discussing and recommending the HPV vaccine to hesitant parents. 
Future research should focus on how providers’ confidence actually impacts adolescent HPV 
vaccination rates, and if more programs like this should be integrated into provider education. 
Other studies included in this literature review focused on provider education on cancer 
prevention, and its impact on vaccination rates (Ferris et al., 2010; Suryadevara et al., 2019). 
Further research should be conducted to discover which educational topics and methods of 
education delivery have a significant impact on increasing HPV vaccination rates in adolescents.   
 One article included in this review focused on the adolescent mother’s healthcare status 




difference in the intent to vaccinate their adolescent between mothers with a well-woman exam 
within the last two years compared to women without a recent exam. However, these researchers 
felt a mother’s well-woman exam could be an additional opportunity for providers to advocate 
for adolescent HPV immunizations and recommend this as an area for further research.  
 When caring for patients who have survived childhood cancer, the provider’s education 
must include the increased likelihood of cancer development from an HPV infection compared to 
a child who has never had cancer. However, there is a lack of research surrounding what 
educational information should be included for parents after their child has completed treatment. 
Further research is necessary to determine how to best address parents of childhood cancer 
survivors (Kirchhoff et al., 2019).  
 Further research studies are needed to determine the impact large scale public health 
messages have on adolescent HPV vaccination series initiation and completion rates (Brewer et 
al., 2020). Several studies were underway at the time of publication, yet additional research 
should be conducted to evaluate the impact of large scale messaging across the nation. Studies 
included in this systematic literature review suggested that education tailored to each parent and 
patient, along with including cultural implications, was more effective than a generalized 
approach (Fenton et al., 2018; Fu et al., 2014; Thomas et al., 2012; Tomas et al., 2013). 
However, further studies on patient-centered and culturally competent care are needed to validate 
and demonstrate the actual impact on HPV vaccination rates in adolescents. Future research 
should also focus on the impact of culturally competent public health messages and its impact on 
adolescent HPV immunization rates.  
As previously mentioned, there is a significant gap in the literature investigating how 




The significant difference between female and male HPV vaccination rates deserves further 
research to identify interventions to meet Healthy People 2030’s goal to have 80% of adolescents 
vaccinated for HPV (Healthy People 2030, n.d.). Increasing the rate of HPV vaccine series 
completion will work towards meeting Healthy People 2030’s goal to reduce the number of HPV 
infections in 20 to 34-year-olds that could be prevented by the nine-valent vaccine (Healthy 
People 2030, n.d.). 
Recommendations for Continuing Provider Education 
 To increase parental education about HPV and the HPV vaccine, healthcare providers 
must be knowledgeable about this topic and comfortable discussing this with parents and 
adolescents. One study focused on an educational intervention given to a group of medical 
students at the University of Minnesota (Twin Cities and Duluth locations) (Schnaith et al., 
2018). Students took a survey before and after a video, lecture, and simulation focusing on the 
HPV vaccine and how to address hesitancy with parents. After the intervention, medical school 
students reported they were more likely to recommend the vaccine overall, more likely to equally 
recommend the vaccine to males and females, and felt more comfortable to talk about the HPV 
vaccine with vaccine hesitant parents (Schnaith et al., 2018). This model could be reproduced as 
a continuing education course for healthcare providers who offer the HPV vaccine in their office. 
Similar interventions could be added to healthcare providers’ education curriculums as well, to 
increase competency and confidence in discussing HPV and the vaccine even as students.  
When recommending the HPV vaccine to parents, the healthcare provider’s message 
must strongly and clearly encourage the parents to vaccinate their adolescent (Kornides et al., 
2018; Suryadevara et al., 2019). In addition, the healthcare provider must be educated to allow 




education courses or school curriculums must encourage providers to highlight cancer prevention 
benefits, include basic information on HPV and its role in cancer development, offering the 
vaccine at each clinic appointment, bundling vaccines and presenting them as equally important, 
and cover how to approach vaccine hesitant parents (Suryadevara et al., 2019).  
Recommendations for Addressing Policy Changes 
Current policies  
At this time there are no federal vaccine requirements to enroll in public schools across 
the U.S. Each state is able to determine its own policies surrounding immunization requirements, 
with only Washington D.C., Virginia, and Rhode Island requiring the HPV vaccine for school 
entry (North & Niccolai, 2016). The rate of HPV vaccinations in the U.S. is significantly lower 
than other school-required vaccines. On average, 63% of girls and 50% of boys had initiated the 
HPV vaccine series (Roberts et al., 2018). However, vaccination rates vary significantly between 
states. The percentage of girls who had initiated the HPV vaccine series ranged from 48% to 
88%, while boys ranged 35% to 81% (Roberts et al., 2018). Rates of series completion were 
lower than rates of vaccine series initiation. Roberts et al. (2018) found that states with multiple 
policy interventions had higher rates of HPV vaccine uptake. Specifically, the combination of 
five policy interventions were associated with the highest HPV vaccine rates in the country. 
These interventions included expansion of Medicaid through the Affordable Care Act to decrease 
financial barriers to vaccination, permitting pharmacists to vaccinate for HPV in local 
pharmacies, vaccine requirement for school entry, mandating sex education classes in schools, 
and no state requirements for parental education on HPV (Roberts et al., 2018). Rhode Island, 
Washington D.C., and Virginia require the HPV vaccine for school entry, but only Rhode Island 




requirements, Virginia has a low HPV vaccine uptake rate. The state also has an expansive 
vaccine exemption policy, which may have undermined the policy’s efforts (Roberts et al., 
2018). Rhode Island has the nation’s highest HPV vaccination rates, which could also be 
attributed to their “Vaccinate Before You Graduate” program (Kaul et al., 2019). This program 
provides the vaccine in schools and a free service (Kaul et al., 2019). However, school-based 
vaccination efforts have not been able to increase vaccination rates to 80%, suggesting that 
further research and interventions are necessary to meet Healthy People 2030’s goal (Kaul et al., 
2019).  
Addressing Existing Disparity Rates with Policy Adoption  
General school vaccination requirements have increased the equity of vaccine coverage 
and promoted long term health of children (North & Niccolai, 2016). However, this review 
suggests that more than a single policy requiring the HPV vaccine for school entry is necessary 
to achieve acceptable vaccination rates (Roberts et al., 2018). Further research is necessary for a 
deeper understanding of which policy combinations yield HPV vaccine uptake rates that meet 
the Healthy People 2020 goals of 80% of the adolescent population (age 13 to 17 years of age) 
completing the series, and how to implement such policies (Roberts et al., 2018). While not an 
easy task, this is critical to the public health of young Americans. Disparities currently exist in 
vaccination rates between races and ethnicities, as well as geographic locations, which may be 
due to a lack of policy surrounding the HPV vaccine series. Hispanic individuals have 66.3% of 
females and 54.2% of males vaccinated. African American females have a slightly higher female 
vaccination rate at 66.4%, but African American males have a significantly lower vaccination 
rate than Hispanic males, at 54.2%. Non-Hispanic white adolescents have consistently lower 




& Niccolai, 2016). Adolescents living in rural communities are 11% less likely to initiate the 
HPV vaccine series (Kaul et al., 2019). 
Recommendations for Non-Policy Public Health Interventions  
If policies surrounding the HPV vaccine cannot be approved by government officials, 
there are non-policy public health interventions that are associated with increased HPV vaccine 
uptake found in the literature. The following reviews several key strategies to consider. 
Universal School Vaccine Programs  
Universal school vaccine programs have been implemented in other high-income 
countries with success (North & Niccolai, 2016). Australia is an example of a successful 
universal school vaccine program. From 2006 to 2011, the country saw an 89.9% decrease in 
anogenital warts in girls age 12 to 17 years old (North & Niccolai, 2016). Australia also saw a 
decrease in cervical cancer precursors in vaccinated girls compared to non-vaccinated girls. Even 
though not all children were vaccinated, there still appears to be possible benefit to the 
population as a whole. Unvaccinated Australian females experienced a 38% decrease in 
anogenital warts during this same time period (North & Niccolai, 2016). Other high-income 
countries that implemented universal school vaccine programs achieved 70% or greater HPV 
vaccine rates, without having school entry vaccine requirements (North & Niccolai, 2016).  
 School vaccination programs have been trialed in the United States. Kaul et al. (2019) 
studied the effect of school based parental education and HPV vaccinations on adolescent 
vaccination rates in the rural, largely Hispanic, economically disadvantaged and medically 
underserved Rio Grande Valley area of Texas. School staff, healthcare staff, and parents reported 
the education on HPV and the vaccine increased their knowledge on this topic. Findings from 




the vaccine in school, can significantly increase vaccine series initiation and completion rates in 
rural, underserved communities. Researchers found that schools that provided both education 
and the vaccine doubled the initiation and completion rates for the HPV vaccine, compared to 
schools who provided education as the only intervention (Kaul et al., 2019). Implementing 
education and school-based vaccines could be a more effective way to increase HPV vaccine 
series initiation and completion rates in the United States. 
Chicago’s Department of Public Health HPV Campaign 
 Another non-policy public health intervention that yielded increased adolescent HPV 
vaccine uptake rates is Chicago’s 2013 to 2014 campaign. The city utilized an $800,000 federal 
grant to create a public health campaign, provide reminders, and train 200 clinicians with an aim 
to increase HPV vaccine uptake in adolescents (North & Niccolai, 2016). By the end of the 
campaign, rates of HPV vaccines increased to 78.1% of females and 64.9% of males (North & 
Niccolai, 2016). Based upon current U.S. HPV vaccination rates, it is clear that some sort of 
intervention is necessary to improve adolescent HPV vaccine series initiation and completion 
rates.  
Future Research 
Multiple factors interact to impact U.S. adolescent HPV vaccination uptake rates. More 
research is needed to determine the role of public policy in adolescent HPV vaccination rates 
(North & Niccolai, 2016). Currently it is up to individual states to determine school vaccine 
requirements. What policy interventions would be most effective at increasing adolescent HPV 
vaccination series initiation and completion? Roberts et al. (2018) recommends further research 
exploring the effect of multiple policies on HPV vaccine uptake, rather than implementation of a 




effective public health interventions, must be completed to meet Healthy People 2030’s goal to 
achieve 80% of adolescents completing the HPV vaccination series. The health of adolescents 
and young adults in the United States depends on this. 
Conclusion 
 A large percentage of the U.S. will contract HPV at some point in their lives. HPV has 
the ability to cause multiple types of cancer. The most current HPV vaccine is effective against 
nine strains of the virus, which account for most cases of cancer and genital warts that are caused 
by HPV. Parents are a key component in reaching Healthy People 2030’s goal to have 80% of all 
adolescents completely vaccinated against HPV. However, education as a sole intervention may 
not be enough to achieve this goal. Utilizing school-based vaccination programs, public health 
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be included in their 
care and given the 
opportunity to make 
health care choices 
to prevent disease. 
Different approaches 
to different parental 
attitudes towards 
vaccines are given. 
Co-administering the 
HPV vaccine with 
other vaccines can 
Providers should 
view every visit as 
an opportunity to 
vaccinate. 
Normalize and 
advocate for the 
HPV vaccine, 
explaining that it 
prevents cancer, 
and it is safe. 
Explain the 
vaccine schedule to 
parents, that it 
requires multiple 
doses. Do not 
delay vaccinating 






boost HPV vaccine 
uptake rates. 
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A., & Simpson, M. 
(2020). Engaging 
communities in preventing 
human papillomavirus-
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uptake rates.  
Total of 21 
participants (11 
in Mesa County, 





years in Mesa 
County, 8-13 




of young adults 
as the vaccine is 
most effective in 
preteens. Settings 
included 
the Denver metro 







a research process 
used to develop 
messages that 
relate to the 
community 
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provided in the 















highlight the benefit 
of protection against 
cancer, and to 
minimize or remove 
statements 
explaining that HPV 
is a sexually 
transmitted disease. 
Participants in the 
urban community 
felt public health 
campaigns on HPV 
should focus on 
correcting 
misconceptions on 
the vaccine. The 
Denver metro cohort 
also felt long-term 
benefits of cancer 
prevention should be 
included, and parents 
of elementary school 
aged children should 
be targeted with 
information on 
increased 
effectiveness of the 
vaccine at a younger 




should be used to 
This research study 
found that 





support the notion 
that public health 
campaigns should 
target the specific 
community they 
will be placed in. 
This study was 
completed on a 






the communities to 
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HPV vaccination by 
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Level III.  
Surveys were used 









the benefits of the 
HPV vaccine in 
ten simple 
statements.” 
Level of education 
and previous HPV 




who reported good 
understanding of 
information given 
from a credible 
professional source 





should focus on 
common 
misconceptions 




be available in 
appropriate 
languages and 
should be simple 
and easy to 
understand. 
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papillomavirus (HPV) 
vaccination motivators, 
barriers, and brochure 
preferences among parents 
in multicultural Hawai’i: 
A qualitative study. 













20 parents with 
children between 








gathered data on 
parent gender, 
race, marital 
status, age, city of 
residence, 
occupation, and 




of HPV vaccines 
in general, 
knowledge and 
attitude on the 
vaccine, physician 
recommendation 
of the vaccine, 





Major themes found 
were “physician is 
critical in the decision 
to vaccinate”, “parental 
perception of the 
child’s sexual activity 
guides the timing of 
their willingness to 
vaccinate”, “HPV 
health education 
materials should be 
provided and discussed 
by the physician”, and 
“parents would prefer 
an educational 
brochure that features 
local faces and 
testimonials, includes 
an immunization chart, 
and addresses barriers 
to vaccination.”  
Educational 
materials should be 




take an active role 
in recommending 
the HPV vaccine 
and should review 
educational 





feedback on 3 
HPV educational 
brochures (which 
focused on parent 
education on HPV 
vaccine).  
Dorell, C., Yankey, D., 
Jeyerajah, J., Stokley, S., 
Fisher, A., Markowitz, L., 
& Smith, P. J. (2014). 
Delay and refusal of 
human papillomavirus 
vaccine for girls, national 
immunization survey-teen, 




given by parents 
of girls age 13-17 




with, and reasons 
for refusing or 
delaying the 
receipt of the 
HPV vaccine.  
4103 parents of 
girls age 13-17 




girls at time of 
















gave data on 
vaccination status.   
 None, this was a 
review of data.  
HPV vaccination rates 
are lower than other 
scheduled vaccination 
rates in the US. Girls 
with parents of higher 
household incomes, 
were non-Hispanic 
white, and had a 
mother with a higher 
education level were 
more likely to delay or 
refuse the HPV 
vaccine. Top concerns 
with the vaccine 
included were possible 
long-term health 
problems from the 
vaccine, concerns if the 
vaccine is effective, 
and parents’ beliefs 
that their daughters do 
not need the vaccine.  
Educating parents 
on HPV vaccine 








vaccine, listen to 
concerns, and 
identify/ help with 





may be more 
effective than from 
the provider alone.  
Fenton, A. T., Elliott, M. 
N., Schwebel, D. C., 
Berkowitz, Z., Liddon, N. 
C., Tortolero, S. R., 
Cuccaro, P. M., Davies, S. 
L., & Schuster, M. A. 
(2018). Unequal 
interactions: Examining 
the role of patient-
centered care in reducing 
inequitable diffusion of a 
medical innovation, the 
human papillomavirus 
The purpose of 
this study was to 
determine the 
role that patient 
centered care has 





and their parents/ 
primary 
caregivers. 


























with follow up 
surveys at 2 and 5 




that patient centered 
care contributes to 
disparity in the 
diffusion of medical 
resources, including 
the HPV vaccine. 
They found some 
patient groups are 
less likely to have 




research on this 
topic. Researchers 
advocate for the 
implementation of 
patient centered 
care for all 
patients, and that 
all patients/ parents 





(HPV) vaccine. Social 
Science & Medicine, 200, 
238-248. 
recommendation of 
the HPV vaccine, 






and race/ ethnicity. 




Ferris, D., Horn, L., & 
Waller, J. L. (2010). 




Journal of the American 
Board of Family 
Medicine, 23(2), 220-229. 
The purpose of 




acceptance of a 
school-based 
HPV vaccine 
program that is 
required. 















personal history of 
HPV infection, 
race/ ethnicity, 
gender (of parent), 
age (of parent and 
child), type of/ lack 
of health insurance, 
knowledge of 
HPV, perceived 
likeliness of child 
to contract HPV, 
safety concerns 
53 question survey 
focused on 
parental opinions 
of HPV, the 




Parents who favored 
requiring the HPV 
vaccine had a personal 
history of HPV, fewer 
financial resources, 
understood their child’s 
risk for contracting 
HPV, were interested 
in getting the vaccine 
for their child, and 
understood that the 
vaccine can prevent 
cervical cancer. Parents 
who were most likely 
to comply with 
mandatory HPV 
vaccinations had 
children 12-14 years 
old and knew the 
vaccine would reduce 
the risk of genital warts 
and cervical cancer.  
Parental and health 
care provider 
education on HPV 
and the vaccine 







Fu, L. Y., Bonhomme, L. 
A., Cooper, S. C., Joseph, 
J. G., & Zimet, G. D. 
(2014). Educational 
interventions to increase 
HPV vaccination 
acceptance: A systematic 



















or young adults, 
and 18 compared 
efficacy of 
different message 
















increase patient or 
parental attitude 
and/or knowledge 











In general, this study 
did not find strong 
evidence for any one 
educational 
intervention that 
could be used for 
wide-spread 
implementation.  
Literature does not 
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Latkin, C. A., & Joseph, J. 
G. (2019). Social 
networks for human 
papillomavirus vaccine 
advice among African 
American parents. Journal 
of Adolescent Health, 
65(1), 124-129. 
The purpose of 
this research was 
to study HPV 
vaccine refusal in 
African 
American 





of 10-12 year old 
children who 
have not yet had 
the HPV vaccine.   
Cross-
sectional. 
Level IV.  
Survey was given 
to parents while 














reviewed the study 
with health care 
providers, and also 
educated providers 





that the study’s 
parents’ advice 




have few members 
in their social 
network that could 
advise them about 
the HPV vaccine. 
However, the few 
individuals they do 
count on can be 
very influential. 





Hansen, C. E., Credle, M., 
Shapiro, E. D., & 
Niccolai, L. M. (2016). “It 
all depends”: A qualitative 
study of parents’ views on 
human papillomavirus 
vaccine for their 
adolescents at ages 11-12 
years. Journal of Cancer 
Education, 31(1), 147-
152. 
The purpose of 




refusing the HPV 
vaccine for their 
11- or 12-year-





female) in a 
primary care 





















Parents had high 
levels of support for 
the HPV vaccine if 
they understood the 
benefits of the 
vaccine (i.e. 
protection from 
genital warts and 
cancer). Researchers 
found even though 
parents who said 




parents were hesitant 
to actually vaccinate 










waiting until their 





parents thought the 
vaccine was not 




perceived as late 
adolescence). 
Researchers found 
that fathers were 
most opposed to the 
vaccination at 11-12 
years old. Overall, 
most parents did 
want to vaccinate 
their children. 
Kaul, S., Do, T. Q. N., 
Hsu, E., Schmeler, K. M., 
Montealegre, J. R., & 
Rodriguez, A. M. (2019). 
School-based human 
papillomavirus 
vaccination program for 
increasing vaccine uptake 
in an underserved area in 
Texas. Papillomavirus 
Research, 8. 













vaccine uptake in 
a rural medically 
underserved area.  
2307 middle 
school students 




























were held in the 
nursing office or 
conference room 








and HPV vaccines 
for parents and 
guardians, school 
nurses and staff, 







Prior to the study, 
intervention schools 
had lower HPV 
vaccination initiation 
and completion rates 
than comparison 
schools. After the 
study’s intervention, 
the intervention 








rates may require 





could be an 
effective way to 
increase HPV 







Kinder, F. D. (2016). 
Parental refusal of the 
human papillomavirus 
vaccine. Journal of 













Philadelphia, PA.  
Mixed-
methods. 







after the well-child 
exam.  
Parents gave 
multiple reasons for 
refusing the HPV 
vaccine for their 
adolescent. Reasons 
included perceived 
need for further 
research, thought the 
vaccine was too new, 
side effects, don’t 
believe it works, lack 
of information, or a 
father wanted to talk 
to the adolescent’s 
mother first. No 
parents reported 
previous education 






The HPV vaccine 
should be offered 
more than once 
(i.e. multiple health 
care visits) to 
given parents time 
to learn and think 








focus on safety, 
especially cancer 
prevention. Allow 
parents a chance to 
ask questions, and 







Kornides, M. L., Fontenot, 
H. B., McRee, A. L., 
Panozzo, C. A., & Gilkey, 
M. B. (2018). 
Associations between 
parents’ satisfaction with 
provider communication 
and HPV vaccination 
behaviors. Vaccine, 
36(19), 2637-2642. 
This study was 
completed to see 





about the HPV 
vaccine and the 
parent’s decision 
to vaccinate, or 
not vaccinate, 
their child. 
795 parents of 
11-17-year-olds 
and discussed the 
HPV vaccine 
with provider at 





created and used 
the HPV Vaccine 
Communication 




confidence in the 




The HPV Vaccine 
Communication 
completed. 




could be an 
important 
component in the 
parent’s HPV 
vaccination decision. 
They also found that 
providers were not 
100% clear on their 
The HPV Vaccine 
Communication 
Scale can be used 




they can improve 
on. Researchers 
also recommend 
clearly stating a 
recommendation 







refusal or delay to 






to the CDC’s 
vaccination 
schedule.  
Lee, H., Kim, M., Kiang, 
P., Shi, L., Tan, K., Chea, 
P., Peou, S., & Grigg-
Saito, D. C. (2016). 
Factors associated with 
HPV vaccination among 
Cambodian American 
teenagers. Public Health 































local Khmer radio 
and TV stations, 
posters around the 
community, and 
word of mouth. 
“Tell-A-Friend 
about Data is 
Power” 




CA girls had higher 
HPV vaccination 
rates than boys (29% 
vs 16%). CA 
mothers had low 
rates of knowledge 
and awareness of 
HPV. Data showed 
that daughters were 
more likely to be 
vaccinated if their 
mother had a higher 
level of English 
reading ability, as 
well as increased 
knowledge and 
awareness of HPV.   
Improved HPV 
vaccine education 
and outreach must 
be implemented to 
increase HPV 
vaccine uptake in 
the CA 
community.  
Litton, A. G., Desmond, 
R. A., Gilliland, J., Huh, 
W. K., & Franklin, F. A. 
(2011). Factors associated 
with intention to vaccinate 
a daughter against HPV: A 
statewide survey in 
Alabama. Journal of 
Pediatric and Adolescent 
Gynecology, 24(3), 166-
171. 
The purpose of 








HPV vaccine of 
Alabamans.  
403 parents of 
daughters age10-








around sex and 




This study found that 




daughter, and only 






to the vaccine are 
not necessarily 
“anti-HPV 
vaccine”. This is 
an opportunity to 
correct 
misperceptions 
about the vaccine, 
discuss benefits, 





Lu, P. J., Yankey, D., 
Jeyarajah, J., O’Halloran, 
A., Elam-Evans, L. D., 
Smith, P. J., Stokley, S., 
Singleton, J. A., & Dunne, 
E. F. (2015). HPV 
vaccination coverage of 
male adolescents in the 
United States. Pediatrics, 
136(5), 839-849. 
Researchers used 




to examine HPV 
vaccine initiation 
and completion 
rates of male 
adolescents. 
They also sought 
to identify any 
factors that may 
predict HPV 
vaccination in 
this population.  
9,554 adolescent 















(parent), number of 
physician visits 
within the last 12 




year well child 
visit, type of health 
care facility 
attended (ex. 
Public or private, 
STD clinic, 
hospital, etc.), and 
geographic area of 




rates for male 
adolescents 
increased from the 
2010 NIS-T survey 
but were still low. 
Male adolescents 
and their parents had 
less awareness of the 
HPV than female 
adolescents and their 
parents. This 
population needs to 
be targeted with 
future interventions 
aimed at increasing 
the HPV vaccine 
series uptake and 
completion. 
Measures should 
also be taken to 
increase vaccine 
coverage in males 
that are least likely 
to be vaccinated. The 
number one barrier 
to vaccinating male 







HPV vaccine series 
to all adolescent 
males and their 
parents. Providers 






Mayer, M. K., Reiter, P. 
L., Zucker, R. A., & 
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Parents’ and sons’ beliefs 






The purpose of 
this study was to 
identify 
adolescent 





547 parents of 
adolescent males 
(age 15-17 


















Most participants did 
not feel that the HPV 





that at the time of the 
survey the HPV 























males, so participant 
answers may be 
different if the study 





tailor how they 
communicate their 
recommendation to 
fit the unique 
parent- adolescent 
dyad. 
Moss, J. L., Gilkey, M. B., 
Rimer, B. K., & Brewer, 

























and HPV vaccine 
initiation.”  
4,124 parents of 
daughters (ages 
13-17 years old). 















of the United 
States, provider use 












Patients who were 
least likely to report 
this style of 
communication were 
“poor, less educated, 
Spanish-speaking, 
Southern, and rural” 
as well as Hispanic 
parents who did not 






with all patients 
and parents as 
another tool to 
increase HPV 
vaccination uptake. 
Moss, J. L., Reiter, P. L., 
Rimer, B. K., & Brewer, 
N. T. (2016b). 
Collaborative patient-
provider communication 
and uptake of adolescent 
vaccines. Social Science & 
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L. M. (2016). Human 
papillomavirus 
vaccination requirements 
in US schools: 
Recommendations for 
moving forward. 
American Journal of 
Public Health, 106(10), 
1765-1770. 
The purpose of 





the US and to 
explore pros and 
cons of such 
policies. 
N/a. This article 
is not a study; it 
is a discussion 
with future 
recommendations 





in the US.  
Expert 
opinion. 
Level VII.  
No tools or 
instruments used 
this was not a 
research study.  
No interventions 
completed this was 
not a research 
study. 
Rationale for 
requiring the HPV 
vaccine for school 
include vaccine 
safety and efficacy, 
possible increased 
vaccine coverage, 












low acceptance rates 
of the vaccine, 
garnering enough 








also provide increase 





officials can weigh 
the pros and cons 
of this discussion. 
This could spark 
ideas for policy 
level interventions 
to increase HPV 
vaccine uptake 
rates.  
Paskett, E. D., Krok-
Schoen, J. L., Pennell, M. 
L., Tatum, C. M., Reiter, 
“To describe and 
















To improve HPV 
vaccination rates, 




P. L., Peng, J., Bernardo, 
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Richardson, M. S., & 
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Results of a multilevel 
intervention trial to 
increase human 
papillomavirus (HPV) 
vaccine uptake among 
adolescent girls. Cancer 
Epidemiology, Biomarkers 
& Prevention, 25(4), 593-
602. 
randomized trial 
(GRT) at the 
county-level 
testing of the 
efficacy of the 













efficacy to discuss 
with parents and 






written survey.   
environment 







on the vaccine and 





brochures and a 
DVD about HPV 
and the vaccine, a 
magnet reminder 
to complete the 
vaccine series, a 
CDC HPV vaccine 
information 
statement, and a 
telephone call 
from health 





education but on 
the flu vaccine).  
vaccine series 
initiation among 
girls ages 9-17. 
However, overall 








each level should 
be utilized. 
Rahman, M., Elam, L. B., 
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visit of mothers and 
human papillomavirus 
vaccine intent and uptake 
among their 9-17 year old 
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The majority of 
participants (78.3%) 
had a well woman 
exam within the last 
2 years. After 
adjusting for vaccine 
awareness, 
household income 





not only be at 





children. Vaccine, 31(47), 
5544-5548. 
HPV vaccine 
uptake for their 
9-17-year-old 
children.  
HPV, and their 
intent to vaccinate 
their adolescent 
children. 
and a personal 
history of an 
abnormal Pap smear, 
there was no 
difference (between 
women with a recent 
well-woman exam 
and women without 
a recent exam) in the 
intent to initiate and 
complete the vaccine 
series for their 
daughters. There was 
no association 
between well-
woman exams and 
the intent to start and 
complete the vaccine 
series in sons.  
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impact on HPV 
vaccination uptake 
rates.  
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rather than single 
policies, are 
related to uptake 
of human 
papillomavirus 
(HPV) vaccine.”  






Level V.  
Utilized data from 
National 
Immunization 







that there was not 
one single policy 
that had a great 
impact on HPV 
vaccine uptake. 
Instead, there were 
sets of policies that 
consistently 
increased HPV 




use this study as a 
reference to 
influence the 
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completed in 4 
safety-net clinics 


























the HPV vaccine. 
Patients in the 
intervention group 
were more likely to 
initiate the HPV 
vaccine series during 
the initial visit, 
though not 
significantly. 
Completion of the 3 
dose series at 12-
Parent education 













vaccination in safety-net 
clinics. BMC Public 




Authors used the 
Intervention 
Fidelity Index to 
create a summed 
score of post-visit 
questionnaire 
answers.  
month follow-up was 
significantly lower 
than the control 
group. Providing 
education materials 
did not increase 
likelihood of 
vaccination at initial 
visit or completion 




during the initial 
visit were 4x more 
likely to initiate the 
vaccine, but not 
complete the series 
by the 12-month 
follow-up.   
study more intense 




efficacy of patient 
education that 
solely focuses on 
HPV vaccine 
instead of all 
adolescent 
vaccines.  
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The purpose of 



















Level III.  
Students surveys 





comfort level in 
talking about the 
HPV vaccine to 
vaccine hesitant 
parents and how 
likely the student 
was to recommend 
the vaccine to these 
parents.  












Students found the 
C.A.S.E. method of 
approaching vaccine 
hesitant parents to be 
most helpful.  
Provider education 




may help increase 
providers’ 
confidence level. 
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of HPV vaccine 
hesitancy and 





Level VI.  
Audio recordings 
were completed 







coded as only 
37 of 43 parents 
expressed HPV 

















Dallas, Texas.  
on how parents 
verbally expressed 
vaccine hesitancy.  





& concerns). When 
providers only used 
persistence to 
respond to hesitancy, 
17/18 adolescents 
were vaccinated. 
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of human 
papillomavirus 





6 large pediatric 




Level IV.  
Anonymous survey 
to assess provider 
and staff baseline 
knowledge and 
beliefs on the 
vaccine and cancer 
prevention. 
Vaccination rates 
and change in rates 
were calculated for 
each clinic. 
Authors compared 
data to other New 
York counties and 
the state’s overall 
HPV vaccination 




retrieved using the 





for providers and 
staff. A cancer 
prevention booklet 
was given to 
adolescents and 
their families.  
Adolescent vaccine 






rates in adolescents 
may be modestly 
improved with 
cancer prevention 
education that is 
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The Health Belief 
Model (HBM) 
provided the 

















knowledge and decisions 
about human 
papillomavirus 













or have already 
vaccinated their 




on HPV, and 
attitudes on HPV 
and the vaccine. 
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refusal of the 
HPV vaccine in a 
rural setting.  
519 parents of 
adolescents (ages 
9-13 years). 




The Health Belief 
Model (HBM) 
provided the 







that parents who 
were not African 
American and were 
not Baptist were two 
to almost 3 times as 
likely to vaccinate or 




found that parents 
who perceived more 
barriers to getting 
the vaccine and 
perceived fewer 
benefits were more 
likely to vaccinate or 
intend to vaccinate 
their children.  
When providing 
education on the 
HPV vaccination 











benefits of cancer 
prevention can also 
help to increase 
vaccine uptake.  
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HPV and the 
HPV vaccine as 
well as child 
experience with 











Parental surveys.  Survey 
completion.  
Researchers found 
that 43.9% of parents 
reported provider 
recommendation of 
the vaccine, and 
32.5% of parents had 
initiated the vaccine 
and 18.8% fully 
vaccinated their 
child at the time the 
study was 
completed. 28.2% of 
parents reported their 
child initiated getting 
Parents and 




There are still gaps 
between male and 
female vaccination 
rates, as well as a 










the vaccine. Parents 
reported that 
scheduling conflicts 
with school or work, 
as well as no 
healthcare provider 
recommendation, 
were barriers to 
vaccinating.  
interventions 
(especially for men 
and minorities) to 
increase 
understanding and 
awareness on HPV 
related cancers and 
the vaccine.  
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vaccination coverage in 
American Indian girls. 
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Level II.  
Baseline surveys 
taken prior to 
intervention. 11-
month follow-up 








mothers on HPV 
(intervention 
group) or juvenile 
diabetes (control). 
By the 11-month 
follow-up survey, 
intervention and 
control groups had 
similar HPV vaccine 
uptake rates. Those 
adolescents who had 
not started the 
vaccine series prior 
to the study, girls 
whose mothers had 
HPV education were 
more likely to start 
the vaccine series 
themselves than girls 
whose mothers were 




on the HPV 
vaccine may be 
more likely to 
initiate the vaccine 
series than girls 
whose mothers do 
not receive 
education on the 
HPV vaccine. 
Providing 
education on the 




daughters, but this 
study suggests the 
rate increase is 
limited. 
 
